drugset / Trial / NCT01128842
A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, phase 1 study of a single cohort of neratinib (HKI-272) in combination with capecitabine.
Timeline
- Start
- 2010-04
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1500 mg/m2 | Oral |
| Subject | Neratinib | Small molecule | 240 mg | Oral |